Orchid Pharma Ltd
Orchid Pharma's GHG Emissions Data Preview
In 2025, Orchid Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Orchid Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Orchid Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Orchid Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Orchid Pharma's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Orchid Pharma amounted to 91,421.7 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Orchid Pharma increased by 118.2%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Orchid Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Orchid Pharma's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Orchid Pharma were 74,800.3 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2024), Orchid Pharma's Scope 1 emissions increased by 21,904.07%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Orchid Pharma's Scope 2 emissions?
In 2025, Orchid Pharma reported Scope 2 greenhouse gas (GHG) emissions of 16,621.4 tCO₂e without specifying the calculation method. a
Has Orchid Pharma reduced its Scope 2 emissions over time?
Compared to the previous year (2024), Orchid Pharma's Scope 2 emissions (Unspecified Calculation Method) fell by 60% in 2025, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a
What methodology does Orchid Pharma use for Scope 2 reporting?
In 2025, Orchid Pharma reported its Scope 2 emissions using an unspecified methodology. a
Orchid Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Orchid Pharma's Value Chain Emissions
In 2025, Orchid Pharma reported 1,968,317 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2025 disclosure of Orchid Pharma includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Orchid Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Orchid Pharma's Scope 3 emissions?
In 2025, Orchid Pharma reported total Scope 3 emissions of 1,968,317 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2024), Orchid Pharma's Scope 3 emissions increased by 89.1%, suggesting that the company faced challenges in reducing emissions across its value chain. a
Insights into Orchid Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Orchid Pharma reported Scope 1 greenhouse gas (GHG) emissions of 74,800.3 tCO₂e and total revenues of USD 108 millions. This translates into an emissions intensity of 693.22 tCO₂e per millions USD. a
Orchid Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Orchid Pharma's GHG emissions intensity compare to its peers?
In 2025, Orchid Pharma reported a Scope 1 emissions intensity of 693.22 tCO₂e per millions USD. Compared to the peer group median of 24.05 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Orchid Pharma rank on GHG emissions intensity within its industry?
In 2025, Orchid Pharma ranked 25 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Orchid Pharma among the least efficient performers, with one of the highest emissions intensities in its sector. a
Insights into Orchid Pharma's Total Carbon Footprint
In 2025, Orchid Pharma reported a total carbon footprint of 2,059,738.7 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 90.23% increase compared to 2024, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Orchid Pharma's total carbon footprint was Scope 3 emissions, accounting for 95.56% of the company's total carbon footprint, followed by Scope 1 emissions at 3.63%. a